Overview

Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if quetiapine is effective in the treatment of PTSD.
Phase:
Phase 4
Details
Lead Sponsor:
Ralph H. Johnson VA Medical Center
Collaborator:
AstraZeneca
Treatments:
Quetiapine Fumarate